Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Woltering

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 11, 2010
Glycine amides as PPARalpha agonistsKlaus Urbahns, Michael Woltering, Susanne Nikolic, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2005
Minor structural modifications convert a selective PPARalpha agonist into a potent, highly selective PPARdelta agonistStefan Weigand, Hilmar Bischoff, Elke Dittrich-Wengenroth, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Novel heterocyclic thyromimeticsHelmut Haning, Michael Woltering, Ulrich Mueller, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|May 11, 2010
Glycine amides as PPARalpha agonistsKlaus Urbahns, Michael Woltering, Susanne Nikolic, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2005
Minor structural modifications convert a selective PPARalpha agonist into a potent, highly selective PPARdelta agonistStefan Weigand, Hilmar Bischoff, Elke Dittrich-Wengenroth, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Novel heterocyclic thyromimeticsHelmut Haning, Michael Woltering, Ulrich Mueller, et al.
Pageof 1